| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |